BNTC Benitec Biopharma Inc.
$12.56
Benitec Biopharma Inc. (BNTC) is expected to report earnings on September 15, 2026, after the market close. The consensus earnings estimate is a loss of $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.7% since its last earnings release on May 14, 2026.
Benitec Biopharma Beat Consensus Estimates
Thursday, May 14, 2026 · 8:00 AM ET
Earnings Date
4th Quarter, Jun 2026
Sep 15
Tuesday · After Close
Earnings Whisper
-
vs ($0.25)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$12.19
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Benitec Biopharma Inc.
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines.
Sector
Healthcare
Industry
Biotechnology